Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism

Journal of Pediatrics

Volumn 163, Issue 2, 2013, Pages 561-567

  Destefano, Frank ^a   Price, Cristofer S ^b   Weintraub, Eric S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ABT ASSOCIATES   (United States)

Author keywords

AD; ADI R; ADOS; ASD; Autism Diagnostic Interview Revised; Autism Diagnostic Observation Schedule; Autism spectrum disorder; Autistic disorder; Managed care organization; MCO; SCQ; Social Communication Questionnaire

Indexed keywords

ANTIBODY STIMULATING PROTEIN; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE; PROTEIN; RABIES VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

ARTICLE; AUTISM; BIRTH; CASE CONTROL STUDY; CHILD; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EXPOSURE; GENDER; HUMAN; IMMUNIZATION; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MANAGED CARE ORGANIZATION; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RISK ASSESSMENT;

AD; ADI-R; ADOS; ASD; AUTISM DIAGNOSTIC INTERVIEW-REVISED; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; AUTISM SPECTRUM DISORDER; AUTISTIC DISORDER; MANAGED CARE ORGANIZATION; MCO; SCQ; SOCIAL COMMUNICATION QUESTIONNAIRE;

ANTIBODIES; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; POLYSACCHARIDES; PROTEINS; RISK ASSESSMENT; VACCINES;

EID: 84880581483     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.02.001     Document Type: Article

References (22)

1. A.J. Wakefield, S.H. Murch, A. Anthony, J. Linnell, D.M. Casson, and M. Malik Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 351 1998 637 641
2. S.K. Parker, B. Schwartz, J. Todd, and L.K. Pickering Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data Pediatrics 114 2004 793 804
3. Institute of Medicine Immunization safety review: vaccines and autism 2004 National Academies Press Washington, DC
4. G.L. Freed, S.J. Clark, A.T. Butchart, D.C. Singer, and M.M. Davis Parental vaccine safety concerns in 2009 Pediatrics 125 2010 654 659
5. J.S. Gerber, and P.A. Offit Vaccines and autism: a tale of shifting hypotheses Clin Infec Dis 48 2009 456 461
6. A. Kennedy, K. LaVail, G. Nowak, M. Basket, and S. Landry Confidence about vaccines in the United States: understanding parents' perceptions Health Affairs 30 2011 1151 1159
7. A.F. Dempsey, S. Schaffer, D. Singer, A. Butchart, M. Davis, and G.L. Freed Alternative vaccination schedule preferences among parents of young children Pediatrics 128 2011 848 856
8. C.S. Price, W.W. Thompson, B. Goodson, E.S. Weintraub, L.E. Croen, and V.L. Hinrichsen Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism Pediatrics 126 2010 656 664
9. C. Price, A. Robertson, and B. Goodson Thimerosal and autism: technical report, vol I 2009 Abt Associates Bethesda (MD)
10. C. Price, A. Robertson, and B. Goodson Thimerosal and autism: technical report, vol II 2009 Abt Associates Bethesda (MD)
11. M. Rutter, A. LeCouteur, and C. Lord Autism diagnostic interview-revised 2003 Western Psychological Services Los Angeles
12. C. Lord, M. Rutter, P.C. DiLavor, and S. Risi Autism diagnostic observation schedule 2003 Western Psychological Services Los Angeles
13. M. Rutter, A. Bailey, and C. Lord SCQ: The Social Communication Questionnaire 2003 Western Psychological Services Los Angeles
14. P.A. Offit, R.L. Davis, and D. Gust Vaccine safety S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 5th ed. 2008 Elsevier London
15. P.A. Offit, J. Quarles, M.A. Gerber, C.J. Hackett, E.K. Marcuse, and T. Kollman Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics 109 2002 124 129
16. M.J. Smith, and C.R. Woods On-time receipt in the first year does not adversely affect neuropsychological outcomes Pediatrics 125 2010 1134 1141
17. Centers for Disease Control and Prevention Recommended immunization schedules for persons aged 0 through 18 years - United States, 2012 MMWR Morb Mortal Wkly Rep 61 2012 1 4
18. G.A. Kuwaik, W. Roberts, L. Zwaigenbaum, S. Bryson, I.M. Smith, and P. Szatmari Immunization uptake in younger siblings of children with autism spectrum disorder Autism 2012
19. E. Courchesne, P.R. Mouton, M.E. Calhoun, K. Semendeferi, C. Ahrens-Barbiau, and M.J. Hallet Neuron number and size in prefrontal cortex of children with autism JAMA 306 2011 2001 2010
20. H.C. Mefford, M.L. Batshaw, and E.P. Hoffman Genomics, intellectual disability, and autism N Engl J Med 366 2012 733 743
21. D. Dudour-Fainfray, P. Vourc'h, S. Tourlet, D. Guilloteau, S. Chalon, and C.R. Andres Fetal exposure to teratogens: evidence of genes involved in autism Neurosci Biobehav Rev 35 2011 1254 1265
22. R. Holt, and A.P. Monaco Links between genetics and pathophysiology in the autism spectrum disorders EMBO Mol Med 3 2011 438 450